The founding father of David Protein, maker of in style high-protein diet bars, announced on X on Monday that longevity guru Dr. Peter Attia “has stepped down from his position as Chief Science Officer at David.”
The announcement comes after Attia’s title appeared in additional than 1,700 paperwork, together with e-mail correspondence, launched on Friday as a part of an enormous file dump associated to convicted intercourse offender Jeffrey Epstein, according to The New York Times. Attia served on the manager group of the meals startup and was additionally an early investor.
For these unfamiliar, Attia is a Canadian-American doctor who has grow to be one of the crucial outstanding voices in longevity and preventive well being. He’s finest identified for his bestselling guide “Outlive: The Science and Artwork of Longevity” and his now seven-year-old podcast, whereby he explores optimization methods. He was additionally employed simply final month as a contributor to CBS.
Three-year-old, New York-based David Protein raised a $75 million Collection A funding spherical in Could of final yr led by Greenoaks, with participation from Valor Fairness Companions. The corporate has skilled vital development since launching its flagship protein bar in September 2024, a product it describes has having 28 grams of protein, zero sugar, and 150 energy.
In a prolonged post on X, Attia wrote that he was “ashamed” of a number of the crude content material in his emails with Epstein, however he additionally mentioned he was not concerned in felony exercise and by no means visited Epstein’s island or traveled on his airplane. Attia additionally mentioned at size how he got here to know Epstein and why he stayed concerned with him even after Epstein’s 2008 conviction.
The fallout seems to increase past David Protein. It additionally seems that Biograph, the well being care testing and longevity startup that Attia co-founded with entrepreneur John Hering, could also be distancing itself from the doctor. The corporate declined to touch upon Attia’s ongoing participation with the startup or in regards to the pages on its web site that used to say him however now omit his title or return a “file not discovered” error.
Biograph got here out of stealth a yr in the past, TechCrunch beforehand reported, with backing from buyers that embody Vy Capital, Human Capital, Alpha Wave, and WndrCo, together with angel buyers together with Balaji Srinivasan. Like a rising variety of concierge medical service firms, Biograph provides premium preventive well being companies to subscribers who pay between $7,500 to $15,000 per yr. Attia was beforehand named on the company’s press release and website as a co-founder.
Techcrunch occasion
Boston, MA
|
June 23, 2026
